SDC1 and Sepsis: We previously found that an increasing level of SDC-1 can be used as a biomarker for predicting diffuse intravascular coagulation (DIC) development with sepsis11 and that non-anticoagulant heparin can improve coagulation by inhibiting the activity of heparinase and reducing the shedding of glycocalyx in sepsis rats37.